DOMENICO COLLETTI: Open Payments
NPI 1851805741 · WALL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,571 in 98 payments from 17 companies in 2025. Trend: 2023 $1,450 · 2024 $1,918 · 2025 $1,571
Food & beverage: $1,571
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $345 |
| LEO Pharma Inc. | 15 | $235 |
| E.R. Squibb & Sons, L.L.C. | 13 | $194 |
| Novartis Pharmaceuticals Corporation | 5 | $129 |
| Incyte Corporation | 6 | $105 |
| Lilly USA, LLC | 5 | $89 |
| PFIZER INC. | 4 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $70 |
| Janssen Biotech, Inc. | 4 | $68 |
| Galderma Laboratories, L.P. | 4 | $66 |
Products named: ADBRY, Sotyktu, SKYRIZI, RINVOQ, OPZELURA, Rhapsido, CIBINQO, TREMFYA.
Industry payments across NJ — which companies pay providers there.
